These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15184457)

  • 1. Performance of the Celera Diagnostics ViroSeq HIV-1 Genotyping System for sequence-based analysis of diverse human immunodeficiency virus type 1 strains.
    Eshleman SH; Hackett J; Swanson P; Cunningham SP; Drews B; Brennan C; Devare SG; Zekeng L; Kaptué L; Marlowe N
    J Clin Microbiol; 2004 Jun; 42(6):2711-7. PubMed ID: 15184457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of Applied Biosystems ViroSeq HIV-1 Genotyping System for sequence-based analysis of non-subtype B human immunodeficiency virus type 1 from Uganda.
    Mracna M; Becker-Pergola G; Dileanis J; Guay LA; Cunningham S; Jackson JB; Eshleman SH
    J Clin Microbiol; 2001 Dec; 39(12):4323-7. PubMed ID: 11724839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of an in-house genotyping resistance test for HIV-1 drug resistance interpretation and genotyping.
    Chen JH; Wong KH; Chan K; Lam HY; Lee SS; Li P; Lee MP; Tsang DN; Zheng BJ; Yuen KY; Yam WC
    J Clin Virol; 2007 Jun; 39(2):125-31. PubMed ID: 17449318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of Celera RUO integrase resistance assay across multiple HIV-1 subtypes.
    Wallis CL; Viana RV; Saravanan S; Silva de Jesus C; Zeh C; Halvas EK; Mellors JW
    J Virol Methods; 2017 Mar; 241():41-45. PubMed ID: 27993614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity and specificity of the ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for detection of HIV-1 drug resistance mutations by use of an ABI PRISM 3100 genetic analyzer.
    Eshleman SH; Crutcher G; Petrauskene O; Kunstman K; Cunningham SP; Trevino C; Davis C; Kennedy J; Fairman J; Foley B; Kop J
    J Clin Microbiol; 2005 Feb; 43(2):813-7. PubMed ID: 15695685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of two commercially available sequence-based HIV-1 genotyping systems for the detection of drug resistance against HIV type 1 group M subtypes.
    Beddows S; Galpin S; Kazmi SH; Ashraf A; Johargy A; Frater AJ; White N; Braganza R; Clarke J; McClure M; Weber JN
    J Med Virol; 2003 Jul; 70(3):337-42. PubMed ID: 12766994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple subtyping assay for human immunodeficiency virus type 1 subtypes B, C, CRF01-AE, CRF07-BC, and CRF08-BC.
    Wei M; Guan Q; Liang H; Chen J; Chen Z; Hei F; Feng Y; Hong K; Huang H; Xing H; Shao Y
    J Clin Microbiol; 2004 Sep; 42(9):4261-7. PubMed ID: 15365021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of HIV type 1 gp41 sequences in diverse HIV type 1 strains.
    Eshleman SH; Hudelson SE; Bruce R; Lee T; Owens MR; Hackett J; Swanson P; Devare SG; Marlowe N
    AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1593-8. PubMed ID: 18160019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of the applied biosystems ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for sequence-based analysis of HIV-1 in pediatric plasma samples.
    Cunningham S; Ank B; Lewis D; Lu W; Wantman M; Dileanis JA; Jackson JB; Palumbo P; Krogstad P; Eshleman SH
    J Clin Microbiol; 2001 Apr; 39(4):1254-7. PubMed ID: 11283037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of the ViroSeq HIV-1 genotyping system v2.0 on HIV-1 strains circulating in Senegal.
    Thiam M; Diop-Ndiaye H; Kebe K; Vidal N; Diakhate-Lô R; Diouara AA; Leye N; Ndiaye O; Sow A; Ngom-Gueye NF; Mboup S; Toure-Kane C
    J Virol Methods; 2013 Mar; 188(1-2):97-103. PubMed ID: 23266258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of an assay for HIV-1 protease and reverse transcriptase drug resistance genotyping of all major group-M subtypes.
    Aitken SC; Kliphuis A; Wallis CL; Chu ML; Fillekes Q; Barth R; Stevens W; Rinke de Wit TF; Schuurman R
    J Clin Virol; 2012 May; 54(1):21-5. PubMed ID: 22306272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of pol integrase sequences in diverse HIV type 1 strains using a prototype genotyping assay.
    Eshleman SH; Hudelson SE; Smith P; Hackett J; Holzmayer V; Swanson P; Devare SG; Marlowe N
    AIDS Res Hum Retroviruses; 2009 Mar; 25(3):343-5. PubMed ID: 19327053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pragmatic approach to HIV-1 drug resistance determination in resource-limited settings by use of a novel genotyping assay targeting the reverse transcriptase-encoding region only.
    Aitken SC; Bronze M; Wallis CL; Stuyver L; Steegen K; Balinda S; Kityo C; Stevens W; Rinke de Wit TF; Schuurman R
    J Clin Microbiol; 2013 Jun; 51(6):1757-61. PubMed ID: 23536405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings.
    Zhou Z; Wagar N; DeVos JR; Rottinghaus E; Diallo K; Nguyen DB; Bassey O; Ugbena R; Wadonda-Kabondo N; McConnell MS; Zulu I; Chilima B; Nkengasong J; Yang C
    PLoS One; 2011; 6(11):e28184. PubMed ID: 22132237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-house human immunodeficiency virus-1 genotype resistance testing to determine highly active antiretroviral therapy resistance mutations in Hong Kong.
    Chen JH; Wong KH; Li PC; Chan KK; Lee MP; To SW; Yam WC
    Hong Kong Med J; 2012 Feb; 18(1):20-4. PubMed ID: 22302906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of HIV-1 antiretroviral resistance from patients with persistently low but detectable viraemia.
    Mackie N; Dustan S; McClure MO; Weber JN; Clarke JR
    J Virol Methods; 2004 Aug; 119(2):73-8. PubMed ID: 15158587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance.
    Buckton AJ; Bissett SL; Myers RE; Beddows S; Edwards S; Cane PA; Pillay D
    J Antimicrob Chemother; 2008 Dec; 62(6):1191-8. PubMed ID: 18927229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains in United States blood donors.
    Brennan CA; Stramer SL; Holzmayer V; Yamaguchi J; Foster GA; Notari Iv EP; Schochetman G; Devare SG
    Transfusion; 2009 Jan; 49(1):125-33. PubMed ID: 18954404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a cost effective in-house method for HIV-1 drug resistance genotyping using plasma samples.
    Chaturbhuj DN; Nirmalkar AP; Paranjape RS; Tripathy SP
    PLoS One; 2014; 9(2):e87441. PubMed ID: 24533056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in Santos, Brazil.
    de Sa-Filho DJ; Soares Mda S; Candido V; Gagliani LH; Cavaliere E; Diaz RS; Caseiro MM
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):347-53. PubMed ID: 18327988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.